B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine
Journal of Experimental Medicine · 01.06.2026 · 223 (6)
DOI: 10.1084/jem.20251094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.04.2026. Verfasst von Mengze Lyu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Immune Tolerance, Nuclear Receptor Subfamily 1, Group F, Member 3, B7-1 Antigen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Regulatory T (Treg) cells that recognize dietary- or microbiota-derived antigens express RORγt and are essential for immune tolerance in the intestine. A recent paradigm shift found these cells require major histocompatibility complex class II (MHCII) on RORγt+ antigen-presenting cells (APCs) rather than conventional dendritic cells (cDCs) for signal one. Here, we evaluate signal two and unexpectedly find that costimulatory molecules B7-1 (CD80) and B7-2 (CD86) antagonize the generation of microbiota-specific RORγt+ Treg cells. Gain-of-function or loss-of-function therapeutics targeting B7 via CTLA-4 exert reciprocal effects on the generation of microbiota-specific RORγt+ Treg cells. This axis was independent of B7 on RORγt+ APCs but required MHCII on this cell type. Finally, CTLA4-Ig treatment restores microbiota-specific RORγt+ Treg cell generation and protects from experimental intestinal inflammation induced by pathobiont colonization with IL-10R signaling blockade. These results define that RORγt+ Treg cells are uniquely restrained by B7 costimulation, while CTLA4-Ig enhances immune tolerance in the intestine when acting cooperatively with RORγt+ APCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
- Department of Microbiology & Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
- Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University , New York, NY, USA.
ORCID-Profile: Mengze Lyu, Gregory F Sonnenberg
Förderung
- NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- Dalton Family Foundation
- Meyer Cancer Center Collaborative Research Initiative
- Burroughs Wellcome Fund
- Linda and Glenn Greenberg
- National Institutes of Health
Zitieren
APA
Lyu, M., & Sonnenberg, G. F. (2026). B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine. Journal of Experimental Medicine, 223(6). https://doi.org/10.1084/jem.20251094
Vancouver
Lyu M, Sonnenberg GF. B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine. Journal of Experimental Medicine. 2026;223(6). doi:10.1084/jem.20251094
BibTeX
@article{Lyu2026,
author = {Lyu, Mengze and Sonnenberg, Gregory F},
title = {B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {6},
doi = {10.1084/jem.20251094}
}
EUVIMED